Dow Jones Newswires: Roche’s vision-loss drug Vabysmo gets EU nod

The approval from the European Commission–the EU’s executive arm–comes after four phase-3 studies showing vision gains and anatomical improvements in patients given the drug, Roche said.


Read More

Previous post UN General Assembly draws dictators, presidents as war hits Europe, threatens Asia – but climate remains focus
Next post 62 and 700: Judge, Pujols closing in on home run milestones